HERA reports on stockpiling of antimicrobials
By Giuliana Miglierini The European Health Emergency Preparedness and Response Authority (HERA) has published the two final reports,…
Some perspectives on green pharmaceuticals
by Giuliana Miglierini The central role the green agenda plays within the EU Commission’s transformative policies impacts also…
European Council’s conclusions on the European Innovation Agenda and research infrastructures
by Giuliana Miglierini The European socio-economic framework is undergoing a profound transformative moment, as a result of the…
What happens after IP loss of protection
by Giuliana Miglierini What does it happen under a competitiveness perspective once intellectual property (IP) protection for medicinal…
How to approach drug substance supply in new product introduction (NPI) processes
by Giuliana Miglierini A key issue to be faced during pharmaceutical development refers to the supply of the…
ACT EU’s Workplan 2022-2026
by Giuliana Miglierini The implementation phase of the Accelerating Clinical Trials in the EU (ACT EU) initiative, launched…